Jan A. Stratmann
Homburg, SL, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy.
Journal: Frontiers in immunology
Published: December 18, 2025
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 13, 2025
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 13, 2025
Treatment Patterns, Outcome, and Quality of Life of Patients With Extensive-Stage SCLC Receiving Third-Line Therapy-Data From the German CRISP Registry (AIO-TRK-0315): A Brief Report.
Journal: JTO clinical and research reports
Published: September 11, 2025
Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 05, 2025
Metabolic phenotype and gender may predict treatment outcomes of atezolizumab in extensive-stage small cell lung cancer.
Journal: Translational lung cancer research
Published: April 15, 2025
The Differential Diagnosis of Thromobocytopenia.
Journal: Deutsches Arzteblatt international
Published: December 31, 2024
Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After EGFR Inhibition.
Journal: Clinical lung cancer
Published: March 26, 2024
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 07, 2024
A pragmatic guide for management of adverse events associated with lorlatinib.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 19, 2023
Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trial.
Journal: ESMO open
Published: August 15, 2023
Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer.
Journal: Frontiers in oncology
Published: August 06, 2023
Last Updated: 09/26/2026